Advanced Life Support (ALS): Opioid Module

Advanced Life Support: Opioid; Enduring Web Course

Original Release Date: 10/19/2022

Last Review Date: August 2022

Termination Date: 10/18/2025

Description

This module is designed to help clinical team members provide immediate treatment and care for victims of opioid overdose. The module educates learners in the pathophysiology of opioid overdose, special considerations on how to care for overdose patients, including naloxone administration, recognizing the need for high-quality CPR, and the use of a defibrillator as indicated. The module offers information on the importance and types of resources available for individuals after an opioid overdose including medication-assisted therapies. This module is aimed at healthcare providers and covers adults only.

Learning Objectives

At the conclusion, participants should be able to:

1. Describe the current opioid epidemic in the United States

2. Explain the pathophysiology of chronic opioid use

3. Describe the pathophysiology of opioid overdose

4. Describe the efficacy of naloxone for opioid overdose

5. Review care considerations for comprehensive treatment after an opioid overdose

Accreditation Terms

Joint Accreditation: 10/19/2022 - 10/18/2025 

CAPCE: 10/19/2022 - 10/18/2025

AARC: N/A

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians

The American Heart Association designates this activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation and Successful Completion

Successful completion of this CE activity includes the following:

1. Complete all portions of the online course

2. Complete the course evaluation

3. Print the Certificate/Statement of Credit

Disclosure Statement

All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.

The following authors/faculty have declared NO financial interest(s) and/or affiliations (check for not conflicts):

Sallie Johnson, PharmD, BCPS

Cameron Dezfulian, MD

Kenneth Navarro, MEd, LP

Comilla Sasson, MD, PhD

Elizabeth Sinz, MD, Ed

Erik Soderberg, MS

Amber Rodriguez, PhD

The list represents the relationships that may be perceived as actual or reasonable conflicts of interest as reported on the Disclosure Questionnaire, which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 24-month period preceding the time that the individual is being asked to assume a role controlling content:

Eric J. Lavonas, MD, MS - BTG Specialty Pharmaceuticals (Research Funding)

Target Audiences

1. Physicians

2. Nurse Practitioners

3. Physician Assistants

4. EMS: Paramedics

ADA Statement

The American Heart Association and American Stroke Association strive to make our websites accessible. The American Heart Association and American Stroke Association are committed to diversity, inclusion, and meeting the needs of all our constituents, including those with disabilities. We are continually improving our digital assets to comply with the accessibility guidelines for levels A and AA in accordance with WCAG 2.1.

If the format of any material on our web pages interferes with your ability to access the information, please contact us to request assistance or if you have questions or comments about our web sites’ accessibility.

Please call 1-800-AHA-USA-1 (1-800-242-8721) or submit an inquiry.